Filing Details

Accession Number:
0001181431-10-031766
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-06-07 13:00:00
Reporting Period:
2010-06-03
Filing Date:
2010-06-07
Accepted Time:
2010-06-07 17:35:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1487371 Genmark Diagnostics Inc. GNMK Surgical & Medical Instruments & Apparatus (3841) 272053069
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1203763 Daryl Faulkner 757 S. Raymond Avenue
Pasadena CA 91105
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-06-03 16,666 $6.00 16,666 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2010-06-03 25,080 $0.00 25,080 $6.93
Common Stock Stock Option (Right to Buy) Acquisiton 2010-06-03 5,785 $0.00 5,785 $6.49
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
25,080 2019-09-24 No 4 J Direct
5,785 2010-06-03 2019-12-22 No 4 J Direct
Footnotes
  1. Received in exchange for options to purchase ordinary shares of Osmetech plc in connection with the reorganization of GenMark Diagnostics, Inc. The reorganization resulted in GenMark becoming the parent company of Osmetech, GenMark's parent company prior to the reorganization, through a scheme of arrangement under Part 26 of the U.K. Companies Act of 2006, but did not alter the proportionate interests of security holders. The number of options issuable pursuant to the reorganization was determined pursuant to an exchange ratio of 230 options to purchase ordinary shares of Osmetech for an option to purchase one share of GenMark common stock.
  2. 33% of the option shares vest and become exercisable on January 20, 2010, January 20, 2011 and January 20, 2012 respectively.